stars 1 stars 2 stars 3

FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The folding and maintenance of proteins in a correctly folded active form is essential to normal cellular function.Accumulation of misfolded proteins, due to mutations or to defects in cellular quality control mechanisms, can prevent them from performing their normal function or result in toxic intermediates.

Foldrx Pharmaceuticals Questions

The Foldrx Pharmaceuticals annual revenue was $5 million in 2026.

Todd Grinnell is the Director, Medical Liaison Group of Foldrx Pharmaceuticals.

1 people are employed at Foldrx Pharmaceuticals.

Foldrx Pharmaceuticals is based in Cambridge, Massachusetts.

The NAICS codes for Foldrx Pharmaceuticals are [4242, 325, 42, 32, 32541, 42421, 424, 3254].

The SIC codes for Foldrx Pharmaceuticals are [512, 51].

Top Foldrx Pharmaceuticals Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users